John Canan
Net worth: 4 M $ as of 31/05/2026
Net worth: 4 M $ as of 31/05/2026
John Canan worked for Merck & Co., Inc. as Senior VP-Finance & Global Controller from 2014 to 2014.
He also worked for Schering-Plough Corp.
as Chief Accounting Officer, SVP & Global Controller from 2009 to 2009, and for Merck Sharp & Dohme Corp.
as Senior Vice President & Controller from 2009 to 2009.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Terex Corp.
Terex Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets aerial work platforms and materials processing machinery 0.06% | 27/04/2026 | 64,456 ( 0.06% ) | 4 M $ | 31/05/2026 |
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Comptroller/Controller/Auditor | 01/03/2014 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Comptroller/Controller/Auditor | 03/11/2009 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Auditor | 01/11/2009 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions